BMS 6073
Generic Name: glyburide/metformin
Pill imprint BMS 6073 has been identified as Glucovance 2.5 mg / 500 mg.
Glucovance is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy.
Glucovance 2.5 mg / 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Glucovance Images
- Generic Name:
- glyburide/metformin
- Imprint:
-
BMS
6073 - Strength:
- 2.5 mg / 500 mg
- Color:
- Orange
- Size:
- 16.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
povidone
croscarmellose sodium
magnesium stearate
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-6073
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66116-0233 | Medvantx Inc (repackager) |
| 54868-4609 | Physicians Total Care Inc (repackager) |
| 68115-0158 | Dispensexpress Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Glucovance resources
- Glucovance
- Glucovance (Wolters Kluwer)
- Glucovance (Cerner Multum)
- Glucovance (Micromedex) - Includes Dosage Information
- Glucovance (FDA)
Search Again
